Sanders Capital LLC Has $4.69 Billion Stake in HCA Healthcare, Inc. (NYSE:HCA)

Sanders Capital LLC raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.2% in the third quarter, Holdings Channel.com reports. The institutional investor owned 11,538,737 shares of the company’s stock after buying an additional 18,175 shares during the quarter. HCA Healthcare makes up about 6.8% of Sanders Capital LLC’s holdings, making the stock its 5th largest holding. Sanders Capital LLC’s holdings in HCA Healthcare were worth $4,689,689,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. Bangor Savings Bank raised its position in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new position in HCA Healthcare during the second quarter valued at $27,000. Unique Wealth Strategies LLC purchased a new stake in HCA Healthcare in the second quarter worth about $28,000. GPS Wealth Strategies Group LLC lifted its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $33,000. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on HCA shares. Oppenheimer raised their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Barclays dropped their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. TD Cowen dropped their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Finally, Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $380.29.

HCA Healthcare Trading Up 0.2 %

HCA stock opened at $325.62 on Tuesday. HCA Healthcare, Inc. has a twelve month low of $245.84 and a twelve month high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock has a market capitalization of $82.48 billion, a price-to-earnings ratio of 14.62, a price-to-earnings-growth ratio of 1.25 and a beta of 1.68. The firm’s fifty day simple moving average is $377.85 and its two-hundred day simple moving average is $358.72.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Buying and Selling

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 in the last 90 days. Company insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.